Baird analyst Ben Kallo maintains First Solar (NASDAQ:FSLR) with a Outperform and raises the price target from $119 to $164.
Expert Ratings for Kymera Therapeutics
Within the last quarter, Kymera Therapeutics (NASDAQ:KYMR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…